Literature DB >> 11585394

MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol.

D A Collie1, R J Sellar, M Zeidler, A C Colchester, R Knight, R G Will.   

Abstract

Creutzfeldt-Jakob Disease (CJD) is a rare, progressive and invariably fatal neurodegenerative disease characterized by specific histopathological features. Of the four subtypes of CJD described, the commonest is sporadic CJD (sCJD). More recently, a new clinically distinct form of the disease affecting younger patients, known as variant CJD (vCJD), has been identified, and this has been causally linked to the bovine spongiform encephalopathy (BSE) agent in cattle. Characteristic appearances on magnetic resonance imaging (MRI) have been identified in several forms of CJD; sCJD may be associated with high signal changes in the putamen and caudate head and vCJD is usually associated with hyperintensity of the pulvinar (posterior nuclei) of the thalamus. These appearances and other imaging features are described in this article. Using appropriate clinical and radiological criteria and tailored imaging protocols, MRI plays an important part in the in vivodiagnosis of this disease. Copyright 2001 The Royal College of Radiologists.

Entities:  

Mesh:

Year:  2001        PMID: 11585394     DOI: 10.1053/crad.2001.0771

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  34 in total

1.  Progress in understanding Creutzfeldt-Jakob disease.

Authors:  Robin J Sellars; Donald A Collie; Robert J Will
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

Review 2.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

Review 3.  Prion diseases.

Authors:  R S G Knight; R G Will
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

4.  Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.

Authors:  C A Heath; R A Barker; T F G Esmonde; P Harvey; R Roberts; P Trend; M W Head; C Smith; J E Bell; J W Ironside; R G Will; R S G Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-20       Impact factor: 10.154

Review 5.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 6.  Other dementias.

Authors:  Gaida Krumina
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

7.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

8.  Tetracyclines affect prion infectivity.

Authors:  Gianluigi Forloni; Selina Iussich; Tazeen Awan; Laura Colombo; Nadia Angeretti; Laura Girola; Ilaria Bertani; Giorgio Poli; Maria Caramelli; Maria Grazia Bruzzone; Laura Farina; Lucia Limido; Giacomina Rossi; Giorgio Giaccone; James W Ironside; Orso Bugiani; Mario Salmona; Fabrizio Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

9.  Prion Diseases: Update on Mad Cow Disease, Variant Creutzfeldt-Jakob Disease, and the Transmissible Spongiform Encephalopathies.

Authors:  Jacqueline Janka; Frank Maldarelli
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

10.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.